Skip to main content
Connection Dental Network

News and Views

Back to search results

Opioid Patient-Prescriber Agreement

Sunday, September 1, 2024 | Posted in GEHA Connection Dental Network News

The Food and Drug Administration (FDA) developed an Opioid Patient-Prescriber Agreement (PPA) as part of its Safe Use Initiative that is available to use and adopt throughout the health care ecosystem.

The intent of this document is to:

  • Create an open conversation between the patient and the prescriber about the benefits, risks, and limitations of opioid medicines;
  • Be used as a decision-making tool before an opioid medicine is used for acute or persistent pain; and
  • Ensure the appropriate and safe use of opioid medicines.

PPA sections:

  • Part 1: For the patient: Deciding whether to use opioid medicines for pain
  • Part 2: For the patient: My promise to using opioid medicines safely
  • Part 3: For the patient and the prescriber

The Opioid PPA is available for any health care professional to aid in fostering a two-way conversation around the topic of safe opioid use and is not mandated, though similar opioid treatment agreements are now being required in some jurisdictions across the U.S.

SOURCES:

Safe Use Initiative - Current Projects | FDA
Opioid Patient Prescriber Agreement (PPA) (fda.gov)
The Legal Landscape for Opioid Treatment Agreements - PubMed

Current (63)

Unfiltered (74)